Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioIntelliSense
AddedFeb 15, 2024
UpdatedJun 18, 2026
BioIntelliSense

BioIntelliSense

Series B

BioIntelliSense offers FDA-approved, medical-grade remote patient monitoring via its BioSticker platform.

HQ
Golden, CO, US
Founded
2018
Overview
Compare
Fundraising
Employees

BioIntelliSense's core mission is to revolutionize healthcare through advanced remote patient monitoring. Their flagship product, the BioSticker, is an FDA-cleared wearable device that provides continuous, at-home monitoring of vital signs and symptoms. The company focuses on enhancing patient care and outcomes by leveraging medical-grade data services.

BioIntelliSense has made significant strides in the healthcare industry, particularly with its BioSticker platform, which supports hospital-at-home initiatives. The company's impact includes improved patient monitoring and reduced hospital readmissions, contributing to more efficient healthcare delivery.

BioIntelliSense - Similar Companies

BioscanR logo

BioscanR

HeartCloud logo

HeartCloud

heartcloud.io

Starling logo

Starling

BioSense logo

BioSense

thebiosense.com

Steth IO logo

Steth IO

stethio.com

HealthSnap logo

HealthSnap

AffirmXH logo

AffirmXH

affirmxh.com

InfoBionic logo

InfoBionic

infobionic.com

Medical Informatics logo

Medical Informatics

michealthcare.com

CaloSense logo

CaloSense

calosense.com

Life365 logo

Life365

life365.health

Tenovi logo

Tenovi

tenovi.com

Healtharc logo

Healtharc

healtharc.io

Praesidium logo

Praesidium

biofi.tech

Vivalink logo

Vivalink

vivalink.com

BioIntelliSense - Quick Facts

Who are BioIntelliSense's competitors?

Companies similar to BioIntelliSense include BioscanR, HeartCloud, Starling and BioSense.

When was BioIntelliSense founded?

BioIntelliSense was founded in 2018.

Where is BioIntelliSense's headquarters located?

BioIntelliSense's headquarters is located in Golden, CO, US.

When was BioIntelliSense's last funding round?

BioIntelliSense's most recent funding round was for $45M (USD) in July 2021.

How much has BioIntelliSense raised to-date?

As of Jul 28, 2021, BioIntelliSense has raised a total of $84.8M (USD).

How many employees does BioIntelliSense have?

BioIntelliSense has 116 employees as of Feb 5, 2024.

BioIntelliSense - Classification

Industry
  • Hardware
Ownership
  • Equity
  • Venture Capital
Technology
  • AI
  • Analytics
  • IoT
  • Telemedicine
Model
  • Platform
Revenue
  • Software
Main Product
  • Medical Devices
  • Remote Patient Monitoring
Tags
  • Data
  • Data Information
  • Healthtech
  • SaaS
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified